Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Infacort · Alkindi Sprinkle, Cortifoam

Small molecule · Agonist of glucocorticoid receptor (NR3C1) · developed by Eton

Approved FDA, Sep 2020
2 Registered trials

What is Infacort?

Infacort (hydrocortisone, Alkindi Sprinkle) is a glucocorticoid that acts as an agonist of the glucocorticoid receptor. It modifies immune responses and metabolic effects.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Alkindi Sprinkle, Cortifoam
Drug type
Small molecule
Targets
glucocorticoid receptor (NR3C1)
Mechanism
Agonist of glucocorticoid receptor (NR3C1)
Pathways
immune_modulation, metabolic_effects
Therapy area
Endocrine
Developer
Eton
In trials of
NBIX
FDA status
Approved as Alkindi Sprinkle, Cortifoam (September 29, 2020), NDA213876 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Apr 21, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT03311932 Phase 1 Adrenal Insufficiency Completed NBIX
NCT03178214 Phase 1 Adrenal Insufficiency Completed NBIX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Adrenal Insufficiency

Other drugs acting on NR3C1

Beclomethasone Dipropionate FDA approved Budesonide FDA approved IDP-118 FDA approved Methylprednisolone FDA approved Mifepristone FDA approved Mometasone FDA approved Mometasone Furoate FDA approved Relacorilant FDA approved Chronocort Phase 3 Exicorilant Phase 1/2 Miricorilant Phase 2 ORIC-101 Phase 1

Sources

Updated Oct 3, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.